Sabrina Orzetti

4PUBLICATIONS
18CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)PharmacogenomicsChemotherapyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|May 25, 2024
Real-World Safety and Outcome of First-Line Pembrolizumab Monotherapy for Metastatic NSCLC with PDL-1 Expression ≥ 50%: A National Italian Multicentric Cohort ("PEMBROREAL" Study).

Alessandro Cafaro, Flavia Foca, Oriana Nanni

|Jan 23, 2024
Improving Drug Safety in Pediatric and Young Adult Patients with Hemato-Oncological Diseases: A Prospective Study of Active Pharmacovigilance.

Anna Parzianello, Giulia Fornasier, Valentina Kiren

|Nov 14, 2023
Toxicity Derived from Interaction between Natural Compounds and Cancer Therapeutic Drugs Metabolized by CYP3A4: Lessons Learned from Two Clinical Case Reports.

Sabrina Orzetti, Paolo Baldo

|Mar 25, 2022
Genetic Therapy and Molecular Targeted Therapy in Oncology: Safety, Pharmacovigilance, and Perspectives for Research and Clinical Practice.

Sabrina Orzetti, Federica Tommasi, Antonella Bertola

Pageof 1

Frequent Collaborators

4 joint publications

Paolo Baldo

1 joint publications

Federica Tommasi

1 joint publications

Giorgia Bortolin

1 joint publications

Elisabetta Caccin